Effect of the organoselenium compound 974zh on the TLR2 and TLR4 gene expression in blood and spleen cells of experimental animals when co-administered with Yersinia pestis EV

One of the important directions for increasing the immunogenic properties of vaccine strains against highly dangerous infections is the search for adjuvants that not only stimulate the immunological effectiveness of vaccination, but can also provide a metabolic correction of the vaccination process. Organoselenium compounds have immunotropic properties and an antioxidant effect, and therefore, the study of the effect of the organoselenium compound 2,6-dipyridinium-9-selenabicyclo[3.3.1]nonane dibromide (974zh) on the activity of the TLR2 and TLR4 gene expression by macroorganism cells of experimental animals immunized with Yersinia pestis EV NIIEG vaccine strain, is a current area of research.
The aim of the work. To assess the TLR2 and TLR4 gene expression by cells of the immune phagocyte system of experimental animals immunized with the Y. pestis EV vaccine strain against the background of immunomodulation with the organoselenium compound 974zh.
Materials and methods. The study was carried out on 125 certified outbred white mice. Biological material (blood, spleen) was disinfected, and the spleen was homogenized. RNA isolation and reverse transcription were performed using commercial reagent kits. The expression level of the TLR2 and TLR4 genes was determined using real-time polymerase chain reaction with specific primers.
Results. When assessing innate immunity using the example of blood and spleen cells of animal models, features of the TLR2 and TLR4 gene expression were revealed in response to the introduction of the Y. pestis EV vaccine strain against the background of immunomodulation with the 974zh. It was found that 974zh induces a statistically significant increase in TLR2 gene expression when co-administered with Y. pestis EV at a dose of both 104 CFU and 103 CFU.
Conclusion. Y. pestis EV against the background of immunomodulation with 974zh, stimulates the expression of the TLR2 and TLR4 genes, which may indicate an increase in the immunogenic properties of the Y. pestis EV vaccine strain under the influence of this preparation.

1. Svitich OA, Lavrov VF, Kukina PI, Iskandaryan AA, Gankovskaya LV, Zverev VV. Agonists of receptors of the innate immunity and defective viral particles as new generation of adjuvants. Epidemiology and Vaccinal Prevention. 2018; 17(1): 76-86. (In Russ.) doi: 10.31631/2073-3046-2018-17-1-76-86

2. Andreev YuYu, Toptygina AP. Adjuvants and immunomodulators in vaccines. Immunologiya. 2021; 42(6): 720-729. (In Russ.) doi: 10.33029/0206-4952-2021-42-6-720-729

3. Koval’chuk LV, Khoreva MV, Nikonova AS. Recognition receptors of innate immunity (NLR, RLR, and CLR). Journal of Microbiology, Epidemiology and Immunobiology. 2011; 88(1): 93-100. (In Russ.)

4. Mamedova LN, Tarasova GN. Clinical and pathogenetic TLR description. Medical Herald of the South of Russia. 2012; (1): 12-15. (In Russ.)

5. Nikonova AA, Khaitov MR, Khaitov RM. Prospects of Toll-like receptor agonists and antagonists for prevention and treatment of viral infections. Medical Immunology (Russia). 2019;21(3):397-406. (In Russ.) doi: 10.15789/1563-0625-2019-3-397-406

6. Kostinov MP, Akhmatova NK, Khromova EA, Kostinova AM. Cytokine Profile in human peripheral blood mononuclear leukocytes exposed to immunoadjuvant and adjuvant-free vaccines against influenza. Front Immunol. 2020; 11(1351): 1-10. doi: 10.3389/fimmu.2020.01351

7. Talayev V, Zaichenko I, Svetlova M, Matveichev A, Babaykina O, Voronina E, et al. Low-dose influenza vaccine Grippol Quadrivalent with adjuvant Polyoxidonium induces a T helper-2 mediated humoral immune response and increases NK cell activity. Vaccine. 2020; 38(42): 6645-6655. doi: 10.1016/j.vaccine.2020.07.053

8. Dubrovina VI, Starovoytova TP, Yurieva OV, Vityazeva SA, Pyatidesyatnikova AB, Ivanova TA, et al. Structural rearrangement of organs of white mice vaccinated with Yersinia pestis EV in combination with organoselenium compound 974zh. Acta biomedica scientifica. 2022; 7(3): 110-120. (In Russ.) doi: 10.29413/ABS.2022-7.3.12

9. Dubrovina VI, Starovoitova TP, Yur’eva OV, Pyatidesyatnikova AB, Potapov VA, Musalov MV, et al. Effect of a synthetic organoselenium compound on post-vaccination immunopoiesis in the red bone marrow and cell composition of peripheral blood of white mice vaccinated with Yersinia pestis EV. Bull Exp Biol Med. 2021; 171: 651-655. doi: 10.1007/s10517-021-05287-0